We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Coherus Oncology
CHRS
$196M
| $3.25M | 0.01% |
181,963
+79,478
| +78% | +$1.35M |
|
1452
Heartland Express
HTLD
$956M
| $3.24M | 0.01% |
155,710
-11,916
| -7% | -$239K |
|
|
BMCH
1453
DELISTED
BMC Stock Holdings, Inc
BMCH
| $3.24M | 0.01% |
128,775
+9,761
| +8% | +$216K |
|
1454
DNOW Inc
DNOW
$2.99B
| $3.22M | 0.01% |
373,172
+6,401
| +2% | +$44K |
|
1455
First Merchants
FRME
$2.67B
| $3.21M | 0.01% |
116,578
+3,244
| +3% | +$86.7K |
|
|
CVGW
1456
DELISTED
Calavo Growers
CVGW
| $3.2M | 0.01% |
50,917
-1,865
| -4% | -$112K |
|
|
ECOL
1457
DELISTED
US Ecology, Inc.
ECOL
| $3.19M | 0.01% |
94,252
+13,882
| +17% | +$452K |
|
1458
Regenxbio
RGNX
$708M
| $3.19M | 0.01% |
86,606
-5,124
| -6% | -$191K |
|
1459
Sturm, Ruger & Co
RGR
$593M
| $3.19M | 0.01% |
41,950
-689
| -2% | -$41.9K |
|
1460
Piper Sandler
PIPR
$5.29B
| $3.19M | 0.01% |
215,420
-16,240
| -7% | -$229K |
|
1461
CarGurus
CARG
$3.47B
| $3.18M | 0.01% |
125,563
+24,930
| +25% | +$581K |
|
1462
Enerpac Tool Group
EPAC
$1.93B
| $3.18M | 0.01% |
180,773
-13,942
| -7% | -$235K |
|
1463
StoneX
SNEX
$7.94B
| $3.15M | 0.01% |
290,253
-29,778
| -9% | -$258K |
|
1464
Under Armour Class C
UA
$2.53B
| $3.14M | 0.01% |
355,177
+23,584
| +7% | +$200K |
|
|
GCP
1465
DELISTED
GCP Applied Technologies Inc.
GCP
| $3.14M | 0.01% |
168,896
-13,207
| -7% | -$237K |
|
|
ADAM
1466
Adamas Trust
ADAM
$883M
| $3.14M | 0.01% |
300,456
-7,718
| -3% | -$67.7K |
|
|
VIVO
1467
DELISTED
Meridian Bioscience Inc
VIVO
| $3.13M | 0.01% |
134,518
-16,722
| -11% | -$242K |
|
1468
Greif
GEF
$5.04B
| $3.13M | 0.01% |
90,987
+3,572
| +4% | +$117K |
|
1469
AMC Global Media
AMCX
$489M
| $3.11M | 0.01% |
132,985
+14,177
| +12% | +$371K |
|
1470
AZZ Inc
AZZ
$4.54B
| $3.11M | 0.01% |
90,603
-3,775
| -4% | -$115K |
|
1471
Lantheus
LNTH
$6.59B
| $3.11M | 0.01% |
217,352
+93,262
| +75% | +$1.23M |
|
1472
Strategy Inc
MSTR
$38.4B
| $3.11M | 0.01% |
262,720
-22,990
| -8% | -$280K |
|
1473
Enanta Pharmaceuticals
ENTA
$400M
| $3.1M | 0.01% |
61,643
+3,714
| +6% | +$192K |
|
1474
Mativ Holdings
MATV
$711M
| $3.08M | 0.01% |
92,200
-9,505
| -9% | -$286K |
|
|
LTHM
1475
DELISTED
Livent Corporation
LTHM
| $3.07M | 0.01% |
498,291
-44,942
| -8% | -$283K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.